Faezzah Baharom

7PUBLICATIONS
49CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustionAllergyNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2026
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.

Andrew S Ishizuka, Christopher M Garliss, Robert N Goddu

|Oct 21, 2024
Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment.

Faezzah Baharom, Dalton Hermans, Lélia Delamarre

|Mar 15, 2024
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.

Junghyun Lim, Ryan Rodriguez, Katherine Williams

|Jan 15, 2021
Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome.

Rico Lepzien, Sang Liu, Paulo Czarnewski

|Jan 15, 2020
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.

Geoffrey M Lynn, Christine Sedlik, Faezzah Baharom

|Jun 18, 2019
Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates.

Joseph R Francica, Richard Laga, Geoffrey M Lynn

Pageof 2

Frequent Collaborators

3 joint publications

Robert A Seder

2 joint publications

Gregory Rankin

2 joint publications

Jamshid Pourazar

2 joint publications

Anders Blomberg